A glycosylphosphatidylinositol anchor signal sequence enhances the immunogenicity of a DNA vaccine encoding Plasmodium falciparum sexual-stage antigen, Pfs230

被引:23
作者
Fanning, SL
Czesny, B
Sedegah, M
Carucci, DJ
van Gemert, GJ
Eling, W
Williamson, KC
机构
[1] Loyola Univ, Dept Biol, Chicago, IL 60626 USA
[2] USN, Med Res Ctr, Malaria Program, Silver Spring, MD 20910 USA
[3] Univ Maryland, Sch Med, Dept Microbiol, Baltimore, MD 21201 USA
[4] Univ Nijmegen, Dept Biol Mol, Nijmegen, Netherlands
关键词
malaria; DNA vaccine; transmission-blocking;
D O I
10.1016/S0264-410X(03)00265-2
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Mammalian expression vectors encoding region C of malaria transmission-blocking vaccine candidate Pfs230 (aa 443-1132) with and without a 3' glycosylphosphatidylinositol (GPI) anchor signal sequence were tested for their immunogenicity in mice. The plasmid containing the GPI anchor signal sequence consistently induced higher titers of anti-Pfs230 antibodies using three delivery systems: intramuscular (i.m.), intradermal (i.d.), and gene gun (g.g.). In contrast, the isotype profile elicited varied depending on the delivery system and was not effected by the presence of the GPI anchor sequence. Both gene gun and intradermal administration induced primarily an IgG1 response, while intramuscular injection induced both IgG1 and IgG2a antibodies. Regardless of the mode of delivery, all the plasmids encoding Pfs230 region C primed for a mixed IgG1/IgG2a response to an intraperitoneal (i.p.) injection of E. coli-produced recombinant Pfs230 region C. None of these vaccination strategies were more effective than r230/MBP.C alone in generating malaria transmission-blocking immunity. Published by Elsevier Science Ltd.
引用
收藏
页码:3228 / 3235
页数:8
相关论文
共 30 条
[1]  
Bustamante PJ, 2000, PARASITE IMMUNOL, V22, P373, DOI 10.1046/j.1365-3024.2000.00315.x
[2]   Transmission blocking malaria vaccines [J].
Carter, R .
VACCINE, 2001, 19 (17-19) :2309-2314
[3]  
Chattergoon MA, 1998, J IMMUNOL, V160, P5707
[4]   IDENTIFICATION OF THE ERYTHROCYTE BINDING DOMAINS OF PLASMODIUM-VIVAX AND PLASMODIUM-KNOWLESI PROTEINS INVOLVED IN ERYTHROCYTE INVASION [J].
CHITNIS, CE ;
MILLER, LH .
JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 180 (02) :497-506
[5]   Modulating the immune response to genetic immunization [J].
Cohen, AD ;
Boyer, JD ;
Weiner, DB .
FASEB JOURNAL, 1998, 12 (15) :1611-1626
[6]  
Feltquate DM, 1997, J IMMUNOL, V158, P2278
[7]   The surface variant antigens of Plasmodium falciparum contain cross-reactive epitopes [J].
Gamain, B ;
Miller, LH ;
Baruch, DI .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (05) :2664-2669
[8]   ANTIBODIES TO PLASMODIUM-FALCIPARUM GAMETE SURFACE-ANTIGENS IN PAPUA-NEW-GUINEA SERA [J].
GRAVES, PM ;
CARTER, R ;
BURKOT, TR ;
QUAKYI, IA ;
KUMAR, N .
PARASITE IMMUNOLOGY, 1988, 10 (02) :209-218
[9]   Plasmid vaccine expressing granulocyte-macrophage colony-stimulating factor attracts infiltrates including immature dendritic cells into injected muscles [J].
Haddad, D ;
Ramprakash, J ;
Sedegah, M ;
Charoenvit, Y ;
Baumgartner, R ;
Kumar, S ;
Hoffman, SL ;
Weiss, WR .
JOURNAL OF IMMUNOLOGY, 2000, 165 (07) :3772-3781
[10]   Transmission-blocking immunity to Plasmodium falciparum in malaria-immune individuals is associated with antibodies to the gamete surface protein Pfs230 [J].
Healer, J ;
McGuinness, D ;
Carter, R ;
Riley, E .
PARASITOLOGY, 1999, 119 :425-433